SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC

NCT04562337 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer

Interventions

DRUG: SHR1316
DRUG: Carboplatin
DRUG: Etoposide
RADIATION: Radiation therapy
DRUG: Cisplatin

Sponsor

Shandong Cancer Hospital and Institute